Procavea Biotech is an ETH Spin-off company developing an innovative protein-based RNA delivery platform. Our focus is to generate siRNA therapeutics in extrahepatic disease areas that are currently unreachable.
Some insights
Our core competence lies in the engineering of computationally-designed protein cages for novel biological functionality. Going forward we look to expand an diversify the team in the areas of pharmacology, pre-clinical disease models, CMC, and eventually clinical development.